These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 27502337

  • 1. Prediction of histological stage based on cystoscopic appearances of newly diagnosed bladder tumours.
    During VA, Sole GM, Jha AK, Anderson JA, Bryan RT.
    Ann R Coll Surg Engl; 2016 Nov; 98(8):547-551. PubMed ID: 27502337
    [Abstract] [Full Text] [Related]

  • 2. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F, Barchetti G, De Berardinis E, Pecoraro M, Salvo V, Simone G, Sciarra A, Leonardo C, Gallucci M, Catalano C, Catto JWF, Panebianco V.
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [Abstract] [Full Text] [Related]

  • 3. Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study.
    Bryan RT, Liu W, Pirrie SJ, Amir R, Gallagher J, Hughes AI, Jefferson KP, Knight A, Nanton V, Mintz HP, Pope AM, Catto JWF, Patel P, James ND.
    Eur Urol; 2021 Jul; 80(1):12-15. PubMed ID: 33653635
    [Abstract] [Full Text] [Related]

  • 4. The accuracy of cystoscopy in predicting muscle invasion in newly diagnosed bladder cancer patients.
    van Straten CGJI, Bruins MH, Dijkstra S, Cornel EB, Kortleve MDH, de Vocht TF, Kiemeney LALM, van der Heijden AG.
    World J Urol; 2023 Jul; 41(7):1829-1835. PubMed ID: 37195314
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Detection and resection of carcinoma in situ of the bladder: Implications for clinical trial design.
    Roumiguié M, Wong A, Belanger E, Wang G, Black PC.
    Urol Oncol; 2023 May; 41(5):254.e9-254.e15. PubMed ID: 36566105
    [Abstract] [Full Text] [Related]

  • 8. Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer.
    Vanneste M, van der Heij B, Christiaansen CE, Berendsen CL, Driessen EJM, Bruins HM.
    World J Urol; 2023 Aug; 41(8):2173-2178. PubMed ID: 37328699
    [Abstract] [Full Text] [Related]

  • 9. Value of multiparametric magnetic resonance imaging for local staging of invasive urinary bladder tumours.
    Huele EH, Veenboer PW, Wessels FJ, Jonges TN, Meijer RP.
    Urol Oncol; 2023 Jan; 41(1):49.e7-49.e12. PubMed ID: 36441069
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
    Del Giudice F, Leonardo C, Simone G, Pecoraro M, De Berardinis E, Cipollari S, Flammia S, Bicchetti M, Busetto GM, Chung BI, Gallucci M, Catalano C, Panebianco V.
    BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
    [Abstract] [Full Text] [Related]

  • 12. Predicting Grade and Stage at Cystoscopy in Newly Presenting Bladder Cancers-a Prospective Double-Blind Clinical Study.
    Mariappan P, Lavin V, Phua CQ, Khan SAA, Donat R, Smith G.
    Urology; 2017 Nov; 109():134-139. PubMed ID: 28818537
    [Abstract] [Full Text] [Related]

  • 13. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
    Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, Hernández V, Kaasinen E, Palou J, Rouprêt M, van Rhijn BWG, Shariat SF, Soukup V, Sylvester RJ, Zigeuner R.
    Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
    Mariappan P, Johnston A, Padovani L, Clark E, Trail M, Hamid S, Hollins G, Simpson H, Thomas BG, Hasan R, Bhatt J, Ahmad I, Nandwani GM, Mitchell IDC, Hendry D, for members of the Scottish Bladder Cancer QPI Research Collaborative.
    Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. New optical imaging technologies for bladder cancer: considerations and perspectives.
    Liu JJ, Droller MJ, Liao JC.
    J Urol; 2012 Aug; 188(2):361-8. PubMed ID: 22698620
    [Abstract] [Full Text] [Related]

  • 18. The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder.
    Mathieu R, Lucca I, Rouprêt M, Briganti A, Shariat SF.
    Nat Rev Urol; 2016 Aug; 13(8):471-9. PubMed ID: 27431340
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
    Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.
    Urol Oncol; 2020 Oct; 38(10):795.e9-795.e17. PubMed ID: 32417111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.